EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Protocol for efficient CRISPR/AAV-mediated genome editing and erythroid differentiation of human hematopoietic stem and progenitor cells

Devesh Sharma, Roshani Sinha, Benjamin J Lesch, M Kyle Cromer

STAR Protocols · 2025-09 · 6 (3) · 104018

DOI: 10.1016/j.xpro.2025.104018 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift STAR Protocols, 2025-09. Verfasst von Devesh Sharma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA; Eli & Edythe Broad Center for Regeneration Medicine, Un…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation, National Institutes of Health, American Society of Gene and Cell Therapy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Here, we present a protocol for genome editing in human hematopoietic stem and progenitor cells (HSPCs) using CRISPR-Cas9 ribonucleoproteins and adeno-associated virus (AAV)-mediated homology-directed repair. We describe steps for AAV production, purification, and titration; HSPC thawing and culture; genome editing; and quantification of editing frequencies. We then detail procedures for erythroid differentiation assays. This protocol ensures high editing efficiency while maintaining cell viability and engraftment potential. For complete details on the use and execution of this protocol, please refer to Chu et al.1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsGene EditingHumansHematopoietic Stem CellsErythroid CellsCell DifferentiationRibonucleoproteinsDependovirusHEK293 Cells

Stichwörter der Autor:innen

Biotechnology and bioengineeringCRISPRCell BiologyCell DifferentiationCell cultureFlow CytometryMolecular BiologyStem Cells

Substanzen

Ribonucleoproteins

Autor:innen und Institutionen

  • Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA; Eli & Edythe Broad Center for Regeneration Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA; Eli & Edythe Broad Center for Regeneration Medicine, University of California, San Francisco, San Francisco, CA 94143, USA; D…

Förderung

  • National Science Foundation
  • National Institutes of Health
  • American Society of Gene and Cell Therapy
  • National Heart Lung and Blood Institute Division of Intramural Research

Zitieren

APA

Sharma, D., Sinha, R., Lesch, B. J., & Cromer, M. K. (2025). Protocol for efficient CRISPR/AAV-mediated genome editing and erythroid differentiation of human hematopoietic stem and progenitor cells. STAR Protocols, 6(3), 104018. https://doi.org/10.1016/j.xpro.2025.104018

Vancouver

Sharma D, Sinha R, Lesch BJ, Cromer MK. Protocol for efficient CRISPR/AAV-mediated genome editing and erythroid differentiation of human hematopoietic stem and progenitor cells. STAR Protocols. 2025;6(3):104018. doi:10.1016/j.xpro.2025.104018

BibTeX
@article{Sharma2025,
  author = {Sharma, Devesh and Sinha, Roshani and Lesch, Benjamin J and Cromer, M Kyle},
  title = {Protocol for efficient CRISPR/AAV-mediated genome editing and erythroid differentiation of human hematopoietic stem and progenitor cells},
  journal = {STAR Protocols},
  year = {2025},
  volume = {6},
  number = {3},
  pages = {104018},
  doi = {10.1016/j.xpro.2025.104018}
}
Kostenlos starten →